QCRH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
QCR Holdings Inc. is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock shows a constructive technical setup, positive analyst support, and no major negative news or insider/congress selling pressure. Given the current pre-market price near support-to-breakout levels and the absence of a bearish signal from Intellectia’s proprietary tools, I would rate it as a buy rather than waiting for a better entry.
QCRH is in a bullish short-to-intermediate trend. MACD histogram is positive and expanding, RSI_6 at 60.339 is neutral-to-bullish without being overbought, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price at 92.24 pre-market is slightly below R1 at 92.818 and above the pivot at 91.231, which suggests the stock is holding a constructive area. The nearby resistance at 93.798 is the next level to watch, while support sits at 89.643. The modeled pattern also suggests positive near-term follow-through.
Analysts remain constructive, with Raymond James raising the target to $99 and keeping Outperform, and Piper Sandler maintaining Overweight with a $107 target. The latest commentary highlighted solid quarterly results, strong expense control, EPS and PPNR beat, stable credit quality, steady-to-improving net interest margin, and growing capital flexibility. There is also no adverse news in the last week, no significant insider selling, no notable hedge fund distribution, and no recent congress trading activity. The stock pattern data also points to modest positive continuation.
Pre-market trading is slightly negative at -0.79%, and the broader market is also weak with the S&P 500 down 0.6%, which can limit upside in the very short term. Analysts did trim one target slightly from $108 to $107 and another from $99 to $98 before the most recent increase, indicating only modest target movement rather than a strong accelerating revision cycle. Financial snapshot data for the latest quarter was unavailable, so there is less direct confirmation from the most recent reported numbers in this dataset.
The latest quarter financial snapshot could not be fully retrieved due to an error, but the available analyst commentary says the quarter was solid. Key takeaways were stronger expense control, an EPS and PPNR beat, slightly weaker revenue, stable credit, improving net interest margin, and increased capital flexibility. The data points to continued fundamental stability rather than deterioration, which supports a long-term bullish view.
Wall Street remains positive on QCRH. Raymond James kept an Outperform rating and raised its target to $99 from $98, while Piper Sandler kept an Overweight rating and set a higher target at $107, though slightly below its prior $108. The pros view is that earnings quality, expense control, balance sheet growth, and capital strength support a premium valuation case. The main con is that upside is still based on valuation discipline and only moderate target changes, not a dramatic re-rating.
